Detalhe da pesquisa
1.
Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
Int J Cancer
; 155(2): 314-323, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491867
2.
Cross-resistance and drug sequence in prostate cancer.
Drug Resist Updat
; 56: 100761, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799049
3.
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Breast Cancer Res Treat
; 184(1): 107-113, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32803636
4.
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Breast Cancer Res Treat
; 185(3): 889, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33226493
5.
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia.
Eur Urol Oncol
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925350
6.
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1225: 123752, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269569
7.
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide.
Biomed Pharmacother
; 169: 115890, 2023 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988848
8.
Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition.
Mol Cancer Ther
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030379
9.
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 29(10): 1887-1893, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917691
10.
CBD-oil as a potential solution in case of severe tamoxifen-related side effects.
NPJ Breast Cancer
; 9(1): 63, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543688
11.
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities.
Pharmaceutics
; 14(9)2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145680
12.
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment.
Ther Adv Med Oncol
; 14: 17588359221081075, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321309
13.
CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients.
Eur J Cancer
; 177: 33-44, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323051
14.
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.
EBioMedicine
; 73: 103681, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749299
15.
Adding metabolic agents to prostate cancer therapy: Every rose has its thorn.
Eur J Cancer
; 170: 305-307, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568678
16.
Influence of Darolutamide on Cabazitaxel Systemic Exposure.
Clin Pharmacokinet
; 61(10): 1471-1473, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895277